Divi ’s, Gland, Fidelity enter race to buy Orchid Pharma

The move comes even as Divi ’s Laboratories, Gland Celsus Bio Chemicals and Fidelity Trading Corporation have evinced interest to take over cephalosporin drugmaker.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news